Covered recipient · General Payments record
HAFEZ GOLZARIAN
General Payments · PY2021–2024
$384.70
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $214.89 | 6 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $154.91 | 3 |
| Acerta Pharma LLC | $23.53 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.81 | 1 |
| Edwards Lifesciences Corporation | $16.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (6)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $12.44 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586074 | CMS |
| Amgen Inc. | $121.78 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586076 | CMS |
| Amgen Inc. | $20.69 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111586078 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.53 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110508742 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.81 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117966431 | CMS |
| Edwards Lifesciences Corporation | $16.64 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138862007 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.